thiazoles has been researched along with dihydropyridines in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (11.67) | 18.7374 |
1990's | 24 (40.00) | 18.2507 |
2000's | 19 (31.67) | 29.6817 |
2010's | 10 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, E; Jacobs, A; Peter, H; Wong, A | 1 |
Alonso, S; Artalejo, CR; Cillero, J; Fau de Casa-Juana, M; García, AG; González-Morales, MA; López, MG; Santos, L; Sunkel, CE; Villarroya, M | 1 |
Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, D | 1 |
Cook, EP; Fragonas, JC; Hunt, NH | 1 |
Bergeron, RJ; Dionis, JB; Egli-Karmakka, M; Frei, J; Huxley-Tencer, A; Peter, HH; Wiegand, J | 1 |
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J | 1 |
Bierer, BE; Nathan, DG | 1 |
Wolfe, LC | 1 |
Chaudhri, G; Clark, IA | 1 |
Finger, J; Hegsted, M; Nathan, DG; Nicolosi, RJ; Peter, H; Renaud, MM; Wolfe, LC | 1 |
Baquet, A; Crichton, RR; Florence, A; Jin, Y; Schneider, YJ | 1 |
Cochrane, CG; Hyslop, PA; Jackson, JH; Sauerheber, R; Schraufstatter, IU; Vosbeck, K; Weitzman, SA | 1 |
Hiller, W; Maichle, C; Schechinger, T; Strähle, J; Weser, U | 1 |
Beaudoin, RL; Gentilini, M; Guillouzo, A; Landau, I; Langlois, P; Mazier, D; Mellouk, S; Miltgen, F; Stahel, E | 1 |
Crichton, RR; Longueville, A | 1 |
Artalejo, CR; Cillero, FJ; de Casa-Juana, MF; de Pascual, R; García, AG; González-Morales, MA; López, MG; Priego, J; Sunkel, C; Villarroya, M | 1 |
Artalejo, AR; de la Fuente, MT; del Valle, M; Gandía, L; García, AG; Montiel, C; Vinet, R | 1 |
Bergeron, RJ; Wiegand, J; Wollenweber, M | 1 |
Algee, SE; Bergeron, RJ; Liu, CZ; McManis, JS; Wiegand, J; Xia, MX | 1 |
DeSousa, M; Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, WD | 1 |
Bergeron, RJ; Creary, EA; Daniels, RD; King, W; Luchetta, G; Moerker, T; Peter, HH; Streiff, RR; Wiegand, J | 1 |
Algee, SE; Bergeron, RJ; McManis, JS; Ratliff-Thompson, K; Wiegand, J; Wollenweber, M | 1 |
Nakagawa, M; Sasaki, S | 1 |
Gandía, L; García, AG; Lara, B; Martínez-Sierra, R; Torres, A | 1 |
Adachi, Y; Fukazawa, M; Kato, T; Suzuki, Y; Tamura, K | 1 |
Diéguez, G; Fernández, N; García, AG; García, JL; López, MG | 1 |
Bergeron, RJ; Ratliff-Thompson, K; Weimar, WR; Wiegand, J | 1 |
Horga, JF; Javaloy, J; Román, JF; Vidal, MT; Zapater, P | 1 |
Crichton, RR; Dexter, DT; Florence, A; Jenner, P; Ward, RJ | 1 |
Bergeron, RJ; Brittenham, GM; Bussenius, J; McManis, JS; Wiegand, J | 1 |
Bergeron, RJ; Weimar, WR; Wiegand, J | 1 |
Baker, E; Chua, AC; Kicic, A | 1 |
Bergeron, RJ; Huang, G; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J | 1 |
Bergeron, RJ; Huang, G; McManis, JS; Weimar, WR; Wiegand, J | 1 |
Bergeron, RJ; Nguyen, JN; Sninsky, CA; Weimar, WR; Wiegand, J | 1 |
Acklin, P; Alberti, D; Buehlmayer, P; Hauffe, S; Lattmann, R; Nick, H; Schupp, J | 1 |
Abboud, KA; Bergeron, RJ; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J | 1 |
Bergeron, J; Bergeron, RJ; Brittenham, GM; Eiler-McManis, E; McManis, JS; Park, JH; Weimar, WR; Wiegand, J | 1 |
Bihel, F; Garino, C; Kraus, JL; Laras, Y; Pietrancosta, N; Quéléver, G; Sheha, M; Wolfe, MS | 1 |
Hu, X; Lu, Q; Qiangrong, P; Wang, T | 1 |
Hider, RC; Zhou, T | 1 |
Bergeron, RJ; Bharti, N; McManis, JS; Wiegand, J | 3 |
Bergeron, RJ; Bharti, N; Rocca, JR; Singh, S; Wiegand, J | 1 |
Bélanger, C; Borgeat, P; Elimam, H; Lefebvre, J; Marleau, S | 1 |
Andreani, A; Bedini, A; Budriesi, R; Chiarini, A; Cosconati, S; Di Toro, R; Ioan, P; Leoni, A; Locatelli, A; Marinelli, L; Novellino, E; Spampinato, S; Ugenti, MP | 1 |
Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J | 3 |
Fan, HW; Hu, Q; Ji, HJ; Xiao, DW; Zhou, XH; Zhu, YB; Zou, JJ | 1 |
Bergeron, RJ; Singh, S; Wiegand, J | 1 |
Kim, SH; Kim, YJ; Koh, SH; Lee, KY; Lee, YJ; Park, HH; Park, KH | 1 |
Abboud, KA; Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J | 1 |
Al-Qasoumi, SI; Al-Said, MS; Bashandy, MS; Ghorab, MM | 1 |
Jójártné, LO; Mártha, C; Szabóné, RP | 1 |
Bedini, A; Budriesi, R; Chiarini, A; Cosconati, S; Ioan, P; Leoni, A; Locatelli, A; Marinelli, L; Micucci, M; Novellino, E; Spampinato, SM | 1 |
Fadda, AA; Refat, HM | 1 |
Aydinok, Y; Berk, G; Cohen, AR; Giardina, PJ; Jeglinski, BI; Kuo, KH; Kwiatkowski, JL; Neufeld, EJ; Pietropaolo, K; Saliba, AN; Taher, AT; Viprakasit, V | 1 |
Dev, A; Jayaprakash, V; Shyam, M; Sinha, BN | 1 |
5 review(s) available for thiazoles and dihydropyridines
Article | Year |
---|---|
[Calcium channel blocker for therapy of patients with hypertension].
Topics: Benzimidazoles; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Thiazoles | 1997 |
Structure-activity relationships among desazadesferrithiocin analogues.
Topics: Animals; Dihydropyridines; Drug Design; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Siderophores; Structure-Activity Relationship; Thiazoles | 2002 |
Development of tridentate iron chelators: from desferrithiocin to ICL670.
Topics: Animals; Benzoates; Callithrix; Chemical Phenomena; Chemistry, Physical; Deferasirox; Dihydropyridines; Dogs; Humans; Iron; Iron Chelating Agents; Rats; Thiazoles; Triazoles | 2003 |
Desferrithiocin: a search for clinically effective iron chelators.
Topics: Animals; Chemistry, Pharmaceutical; Dihydropyridines; Drug Design; Electron Transport; Ferritins; Homeostasis; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Oxidation-Reduction; Primates; Rats; Rats, Sprague-Dawley; Siderophores; Structure-Activity Relationship; Thiazoles; Transferrin | 2014 |
Scaffold Based Search on the Desferithiocin Archetype.
Topics: Benzene Derivatives; Dihydropyridines; Humans; Iron Chelating Agents; Iron Overload; Pyridines; Structure-Activity Relationship; Thiazoles | 2019 |
2 trial(s) available for thiazoles and dihydropyridines
Article | Year |
---|---|
Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Antipsychotic Agents; Azetidinecarboxylic Acid; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dihydropyridines; Female; Humans; Isoindoles; Male; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2008 |
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Cyclohexanones; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Kidney Diseases; Middle Aged; Siderophores; Thiazoles; Young Adult | 2017 |
53 other study(ies) available for thiazoles and dihydropyridines
Article | Year |
---|---|
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain | 1992 |
Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Cations; Dihydropyridines; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium; Rabbits; Rats; Rats, Inbred Strains; Thiazoles | 1992 |
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
Topics: Animals; Cytokines; Dihydropyridines; Graft Survival; Heart Transplantation; Iron Chelating Agents; Lymphocyte Activation; Macrophage Activation; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Receptors, Interleukin-2; T-Lymphocytes; Thiazoles; Transplantation, Homologous | 1992 |
Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes.
Topics: Animals; B-Lymphocytes; Deferoxamine; Dihydropyridines; DNA; Ferricyanides; Humans; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxygen; T-Lymphocytes; Thiazoles | 1991 |
Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.
Topics: Administration, Oral; Animals; Bile; Chemical Phenomena; Chemistry; Dihydropyridines; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazoles | 1991 |
A comparative evaluation of iron clearance models.
Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles | 1990 |
The effect of desferrithiocin, an oral iron chelator, on T-cell function.
Topics: Antigens, Surface; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Cytotoxicity, Immunologic; Deferoxamine; Dihydropyridines; Humans; Interleukin-2; Iron; Iron Chelating Agents; Killer Cells, Natural; Lymphocyte Activation; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thiazoles | 1990 |
Desferrithiocin.
Topics: Animals; Dihydropyridines; Iron Chelating Agents; Thiazoles | 1990 |
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.
Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Deferoxamine; Dihydropyridines; Free Radicals; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred CBA; Oxygen; Peritoneal Cavity; Thiazoles; Tumor Necrosis Factor-alpha | 1989 |
A non-human primate model for the study of oral iron chelators.
Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Dihydropyridines; Disease Models, Animal; Injections, Intramuscular; Iron; Iron Chelating Agents; Thiazoles | 1989 |
Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization.
Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Iron; Liver; Male; Rats; Rats, Inbred Strains; Thiazoles; Tritium | 1989 |
Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke.
Topics: Asbestos; Bacteriophages; Benzoates; Benzoic Acid; Catalase; Dihydropyridines; Dimethyl Sulfoxide; DNA; Drug Synergism; Electron Spin Resonance Spectroscopy; Hydroxides; Hydroxyl Radical; Mannitol; Nucleic Acid Conformation; Phenanthrolines; Smoking; Superoxide Dismutase; Thiazoles | 1987 |
A five-coordinate copper complex with superoxide dismutase mimetic activity from Streptomyces antibioticus.
Topics: Circular Dichroism; Copper; Dihydropyridines; Electron Spin Resonance Spectroscopy; Iron Chelating Agents; Models, Molecular; Spectrophotometry; Streptomyces; Streptomyces antibioticus; Superoxide Dismutase; Thermodynamics; Thiazoles; X-Ray Diffraction | 1988 |
Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Humans; Iron Chelating Agents; Liver; Malaria; Microscopy, Electron; Plasmodium falciparum; Plasmodium yoelii; Rats; Thiazoles | 1988 |
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles | 1986 |
PCA 50941, a novel Ca2+ channel agonist.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium Channel Agonists; Cardiovascular System; Dihydropyridines; Heart Atria; In Vitro Techniques; Isradipine; Mesenteric Arteries; Muscles; Nitrendipine; Rabbits; Rats; Rats, Sprague-Dawley; Swine; Thiazoles; Vasoconstriction | 1993 |
Interactions between Ca2+, PCA50941 and Bay K 8644 in bovine chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Medulla; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Catecholamines; Cattle; Cell Membrane; Cytosol; Dihydropyridines; Fura-2; In Vitro Techniques; Isradipine; Patch-Clamp Techniques; Potassium; Thiazoles | 1994 |
An investigation of desferrithiocin metabolism.
Topics: Animals; Chromatography, High Pressure Liquid; Cysteine; Dihydropyridines; Female; Hydrolysis; Iron; Kinetics; Male; Mice; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles | 1994 |
The desferrithiocin pharmacophore.
Topics: Animals; Dihydropyridines; Drug Design; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1994 |
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
Topics: Animals; Cell Movement; Dihydropyridines; Graft Survival; Heart Transplantation; Iron; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Siderophores; T-Lymphocyte Subsets; Thiazoles; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 1993 |
A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
Topics: Animals; Cebus; Deferoxamine; Dihydropyridines; Feces; Gastrointestinal Diseases; Iron; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles | 1993 |
Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators.
Topics: Animals; Cebus; Dihydropyridines; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Thiazoles | 1996 |
Q-type Ca2+ channels are located closer to secretory sites than L-type channels: functional evidence in chromaffin cells.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Catecholamines; Cattle; Chromaffin Cells; Dihydropyridines; In Vitro Techniques; Neurosecretory Systems; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Piperidines; Potassium; Spider Venoms; Thiazoles | 1998 |
CP-060S interacts with three principal binding sites on the L-type Ca2+ channel.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Heart; In Vitro Techniques; Kinetics; Male; Myocardium; Radioligand Assay; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines | 1998 |
PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Agonists; Coronary Circulation; Dihydropyridines; Endothelin-1; Female; Goats; Heart; Heart Rate; Infusions, Intravenous; Shock, Cardiogenic; Thiazoles; Ventricular Function, Left | 1998 |
The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties.
Topics: Animals; Cebus; D-Amino-Acid Oxidase; Deferoxamine; Dihydropyridines; Iron; Iron Chelating Agents; Kinetics; Male; Metabolic Clearance Rate; Molecular Structure; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1998 |
Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.
Topics: Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Clonazepam; Dihydropyridines; Electroshock; Female; Male; Mice; Mice, Inbred Strains; Nimodipine; Pentylenetetrazole; Phenytoin; Seizures; Thiazoles | 1998 |
Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
Topics: Administration, Oral; Animals; Corpus Striatum; Dihydropyridines; Dopamine; Ferrous Compounds; In Vitro Techniques; Iron; Iron Chelating Agents; Iron Overload; Male; Metallocenes; Rats; Rats, Wistar; Serotonin; Thiazoles | 1999 |
Evaluation of the desferrithiocin pharmacophore as a vector for hydroxamates.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Drug Evaluation, Preclinical; Hydroxamic Acids; Injections, Subcutaneous; Iron Chelating Agents; Iron Overload; Ligands; Male; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles | 1999 |
Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Humans; Iron Chelating Agents; Serum Albumin; Thiazoles | 1999 |
Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Fibroblasts; Hepatocytes; Humans; Iron; Iron Chelating Agents; Male; Mice; Rats; Rats, Wistar; Thiazoles; Tumor Cells, Cultured | 2002 |
Desferrithiocin analogue based hexacoordinate iron(III) chelators.
Topics: Animals; Ascorbic Acid; Bile; Cebus; Dihydropyridines; Feces; Free Radical Scavengers; Iron; Iron Chelating Agents; Ligands; Oxidation-Reduction; Resorcinols; Structure-Activity Relationship; Thiazoles | 2003 |
Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.
Topics: Acetic Acid; Animals; Colitis; Dihydropyridines; Disease Models, Animal; Drug Interactions; Intestinal Mucosa; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Thiazoles | 2003 |
Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier.
Topics: Animals; Cebus; Crystallography, X-Ray; Dihydropyridines; Feces; Humans; Iron Chelating Agents; Mice; Stereoisomerism; Thiazoles | 2003 |
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.
Topics: Animals; Antioxidants; Ascorbic Acid; Catechols; Cebus; Dihydropyridines; Free Radical Scavengers; Humans; In Vitro Techniques; Iron; Iron Chelating Agents; Liver; Male; Myocardium; Oxidation-Reduction; Pancreas; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Tissue Distribution | 2005 |
Substituted thiazolamide coupled to a redox delivery system: a new gamma-secretase inhibitor with enhanced pharmacokinetic profile.
Topics: Alzheimer Disease; Amides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Biological Availability; Blood-Brain Barrier; Dihydropyridines; Drug Delivery Systems; Endopeptidases; Enzyme Inhibitors; Humans; Male; Molecular Structure; Nicotinic Acids; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Thiazoles | 2005 |
Schisandrin B--a novel inhibitor of P-glycoprotein.
Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Models, Chemical; Neoplasms; Polycyclic Compounds; Protein Binding; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
The design of orally active iron chelators.
Topics: Administration, Oral; Benzoates; Clinical Trials as Topic; Deferasirox; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Humans; Iron; Iron Chelating Agents; Ligands; Models, Molecular; Molecular Structure; Oxidation-Reduction; Pyridones; Thiazoles; Triazoles | 2005 |
The design, synthesis, and evaluation of organ-specific iron chelators.
Topics: Animals; Bile; Carboxylic Acids; Cebus; Dihydropyridines; Iron Chelating Agents; Iron-Dextran Complex; Kidney; Liver; Male; Myocardium; Organ Specificity; Pancreas; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Tissue Distribution | 2006 |
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.
Topics: Animals; Cebus; Dihydropyridines; Iron; Iron Chelating Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Species Specificity; Thiazoles; Tissue Distribution | 2007 |
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.
Topics: Animals; Benzopyrans; Carboxylic Acids; Dermatitis; Dihydropyridines; Imidazoles; Leukotriene B4; Male; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumonia; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Skin; Thiazoles | 2008 |
Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
Topics: Animals; Binding Sites; Computer Simulation; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Heart; Heart Rate; Imidazoles; Ligands; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Myocardial Contraction; Myocytes, Cardiac; Small Molecule Libraries; Structure-Activity Relationship; Thiazoles | 2008 |
Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.
Topics: Animals; Biliary Tract; Cercopithecus; Dihydropyridines; Drug Design; Ether; Iron; Iron Chelating Agents; Kidney; Kinetics; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2008 |
Desferrithiocin analogues and nephrotoxicity.
Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Ligands; Lipids; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Water | 2008 |
Desferrithiocin analogue uranium decorporation agents.
Topics: Animals; Bile Ducts; Chelating Agents; Dihydropyridines; Dose-Response Relationship, Drug; Femur; Kidney; Ligands; Liver; Lung; Pentetic Acid; Rats; Spleen; Thiazoles; Uranium | 2009 |
Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway.
Topics: Analysis of Variance; Animals; Apoptosis; Calcium Channel Blockers; Cell Differentiation; Cell Survival; Dihydropyridines; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Free Radical Scavengers; Hydrogen Peroxide; Indoles; Neurons; omega-Conotoxins; Oxidants; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Tetrazolium Salts; Thiazoles | 2009 |
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.
Topics: Animals; Bile Ducts; Cebus; Chemical Phenomena; Crystallography, X-Ray; Dihydropyridines; Drug Design; Ether; Ethers; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Octanols; Rats; Thiazoles; Water | 2010 |
Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dihydropyridines; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Thiazoles; Thiophenes | 2011 |
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity.
Topics: Animals; Cebus; Cell Adhesion Molecules; Dihydropyridines; Feces; Iron; Iron Chelating Agents; Kidney; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Thiazoles | 2011 |
[Amorphous form in pharmaceutical technological research].
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chlorhexidine; Clopidogrel; Dihydropyridines; Gemfibrozil; Glass; Ibuprofen; Loratadine; Meloxicam; Pharmaceutical Preparations; Piroxicam; Sorbitol; Technology, Pharmaceutical; Thiazines; Thiazoles; Ticlopidine | 2011 |
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
Topics: Administration, Oral; Animals; Cebus; Coordination Complexes; Dihydropyridines; Ethers; Ferric Compounds; Hydroxylation; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2012 |
Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole-1,4-dihydropyridines: from heart activity to brain affinity.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cerebral Cortex; Computer Simulation; Dihydropyridines; Guinea Pigs; Heart; Heart Rate; Imidazoles; In Vitro Techniques; Models, Molecular; Muscle, Smooth; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Rats; Structure-Activity Relationship; Thiazoles | 2013 |
Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzopyrans; Candida albicans; Dihydropyridines; Dose-Response Relationship, Drug; Escherichia coli; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Thiophenes | 2013 |